Loss of p21 Expression in Gastric Carcinoma and Its Correlation with Disease Progression
Author Information
Author(s): M Ogawa, K Maeda, N Onoda, Y-S Chung, M Sowa
Primary Institution: Osaka City University Medical School
Hypothesis
Does the loss of p21 protein expression correlate with disease progression in gastric carcinoma?
Conclusion
Loss of p21 expression in primary gastric carcinoma correlates with disease progression and indicates a poorer prognosis.
Supporting Evidence
- 60.4% of the tumor tissues showed loss of p21 expression.
- Patients with p21-negative tumors had a significantly higher risk of recurrence after surgery.
- Loss of p21 expression was more frequent in patients with lymph node, liver, or peritoneal metastases.
Takeaway
This study found that when a protein called p21 is missing in stomach cancer, the disease tends to get worse and patients do not do as well.
Methodology
Immunohistochemical staining was used to assess p21 protein expression in 172 primary gastric carcinoma specimens.
Limitations
The study is retrospective and may not account for all variables affecting prognosis.
Participant Demographics
The study included 110 men and 62 women, aged 28 to 82 years, with an average age of 59.5 years.
Statistical Information
P-Value
<0.0001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website